Completed Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer NCT01037790 Conditions Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Adult Central Nervous System Germ Cell Tumor, +74 more Locations Abramson Cancer Center of The University of Pennsylvania — Philadelphia, Pennsylvania, United States View Trial Details
Completed Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors NCT00957905 Conditions Endocrine Gland Neoplasms, Endocrine System Diseases, Genital Diseases, +19 more Locations Tower Cancer Research Foundation — Beverly Hills, California, United States City of Hope Comprehensive Cancer Center — Duarte, California, United States USC / Norris Comprehensive Cancer Center — Los Angeles, California, United States University of California Davis Comprehensive Cancer Center — Sacramento, California, United States View more locations Show fewer locations Loading locations... View Trial Details
